Coenzyme I for blood recovery after cord blood transplant
Part of Blood & lymphatic clinical trials.
This trial tests whether a drug called Coenzyme I (given by injection) can help your blood cells recover faster after a cord blood transplant for blood cancer. It is for people who are getting this type of transplant for the first time and are in fairly good health otherwise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have a blood cancer and are getting a single-unit cord blood transplant for the first time.
- Your major organs (heart, liver, kidneys, pancreas) are working well, and you have no active infections.
- You are able to care for yourself and are up and about at least half the day (ECOG score 0-2).
- You and your family agree to try the study drug, Coenzyme I, given by injection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called Romiplostim N01 to help platelet levels recover faster in people with blood cancers who have had a cord blood transplant. It may reduce the need for platelet transfusions and lower bleeding risk.
This study looks at how a type of immune cell called gamma-delta T cells recovers in your body after a cord blood transplant. It may help doctors understand how to improve recovery and reduce complications.
This trial tests if a natural compound called sulforaphane can help your blood cells recover faster after a cord blood transplant for high-risk blood cancers. If you qualify, you would receive this supplement along with your transplant.
This study tests whether umbilical cord blood cells can help people whose blood counts stay dangerously low after immune-based cancer treatments like CAR-T or bispecific antibodies. The treatment aims to boost your blood cell recovery and reduce the need for transfusions.
This Phase 1/2 study tests whether a specific immune-cell “starter” injection (HTLP) can help adults rebuild their immune system faster after an umbilical cord blood transplant for blood cancers. It mainly focuses on safety and whether immune recovery improves.
This trial tests whether infusing stem cells from umbilical cord blood can help your bone marrow recover and make healthy blood cells again after chemotherapy. The goal is to improve your blood counts and reduce the need for transfusions.
Hear when a new Hematopoietic Recovery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.